Ms Lisa D Biehl, ARNP | |
875 Wesley St Ste 250, Arlington, WA 98223-1668 | |
(360) 435-2233 | |
(360) 435-3966 |
Full Name | Ms Lisa D Biehl |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 875 Wesley St Ste 250, Arlington, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376622852 | NPI | - | NPPES |
9608134 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363L00000X | Nurse Practitioner | AP30002411 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Lisa D Biehl, ARNP 875 Wesley St Ste 250, Arlington, WA 98223-1668 Ph: (360) 435-2233 | Ms Lisa D Biehl, ARNP 875 Wesley St Ste 250, Arlington, WA 98223-1668 Ph: (360) 435-2233 |
News Archive
Writing on the U.S. Global Leadership Coalition's website, Sarah Sagely Klotz, executive director of Hamlin Fistula USA, reports on how private U.S. investments "are building maternal care capacity and producing tremendous results" in Ethiopia.
Most children with HIV who have low levels of a key immune cell eventually recover levels of this cell after they begin treatment, according to a new study conducted by researchers at UCLA and other institutions in the U.S. and Brazil.
Ellex Medical Lasers Limited, a global leader in the design and manufacture of ophthalmic laser and ultrasound systems, today announced that it will introduce the latest version of the Eye Cubed(TM) diagnostic ultrasound system at the annual meeting of the American Academy of Ophthalmology (AAO), October 24 - 27, 2009 in San Francisco.
Maxim Pharmaceuticals has announced that based upon the negative outcome of it's confirmatory Phase 3 clinical trial (M0104) studying Ceplene(TM) (histamine dihydrochloride) in combination with Interleukin-2 (IL-2) in advanced malignant melanoma patients with liver metastases, it plans to close the treatment protocol approved by the FDA earlier this year.
ViroPharma Incorporated has announced that the U.S. Food and Drug Administration (FDA) has granted priority review for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of Hereditary Angioedema (HAE).
› Verified 8 days ago
Kitty Carmichael, ARNP, CDE Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 7530 204th St Ne, Arlington, WA 98223 Phone: 360-435-7337 Fax: 360-435-3510 | |
Ms. Ruth Elizabeth Wolff, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 875 Wesley St, Suite 210, Arlington, WA 98223 Phone: 360-403-8158 Fax: 360-403-7098 | |
Kay L Moua, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 16404 Smokey Point Blvd, Suite 102, Arlington, WA 98223 Phone: 425-318-7144 Fax: 425-748-7378 | |
Mrs. Sharon K Clifner, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 21528 87th Ave Ne, Arlington, WA 98223 Phone: 360-433-0779 | |
Anna Swanson Thomas, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 326 S Stillaguamish Ave, Arlington, WA 98223 Phone: 360-572-5400 Fax: 360-572-5401 | |
Mrs. Holly Alison Eunice Vick, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 20210 77th Ave Ne, Arlington, WA 98223 Phone: 360-862-6869 | |
Dr. Cathy L Fliris, DNP, ARNP, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 540 N West Ave, Arlington, WA 98223 Phone: 360-435-8262 Fax: 360-474-1394 |